nodes	percent_of_prediction	percent_of_DWPC	metapath
Naftifine—Skin tenderness—Estradiol—prostate cancer	0.0543	0.0896	CcSEcCtD
Naftifine—Pain of skin—Estradiol—prostate cancer	0.0266	0.0438	CcSEcCtD
Naftifine—SQLE—prostate gland—prostate cancer	0.0247	0.299	CbGeAlD
Naftifine—SQLE—Regulation of cholesterol biosynthesis by SREBP (SREBF)—MBTPS1—prostate cancer	0.0188	0.0708	CbGpPWpGaD
Naftifine—SQLE—Statin Pathway—ABCG5—prostate cancer	0.0164	0.0617	CbGpPWpGaD
Naftifine—SQLE—SREBP signalling—MBTPS1—prostate cancer	0.0152	0.0574	CbGpPWpGaD
Naftifine—SIGMAR1—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.0149	1	CbGdCrCtD
Naftifine—Inflammation—Degarelix—prostate cancer	0.0145	0.0239	CcSEcCtD
Naftifine—Scab—Capecitabine—prostate cancer	0.0123	0.0203	CcSEcCtD
Naftifine—Dermatitis bullous—Flutamide—prostate cancer	0.0119	0.0196	CcSEcCtD
Naftifine—Swelling—Degarelix—prostate cancer	0.0116	0.0191	CcSEcCtD
Naftifine—SQLE—testis—prostate cancer	0.0109	0.132	CbGeAlD
Naftifine—Blister—Conjugated Estrogens—prostate cancer	0.0109	0.0179	CcSEcCtD
Naftifine—SIGMAR1—prostate gland—prostate cancer	0.0103	0.125	CbGeAlD
Naftifine—Redness—Estradiol—prostate cancer	0.00928	0.0153	CcSEcCtD
Naftifine—SIGMAR1—seminal vesicle—prostate cancer	0.00875	0.106	CbGeAlD
Naftifine—SQLE—Activation of gene expression by SREBF (SREBP)—NCOA2—prostate cancer	0.00856	0.0322	CbGpPWpGaD
Naftifine—Inflammation—Conjugated Estrogens—prostate cancer	0.00807	0.0133	CcSEcCtD
Naftifine—SQLE—lymph node—prostate cancer	0.00789	0.0954	CbGeAlD
Naftifine—SQLE—Statin Pathway—LPL—prostate cancer	0.00767	0.0289	CbGpPWpGaD
Naftifine—SQLE—Activation of gene expression by SREBF (SREBP)—NCOA1—prostate cancer	0.00721	0.0272	CbGpPWpGaD
Naftifine—Leukopenia—Estramustine—prostate cancer	0.00694	0.0114	CcSEcCtD
Naftifine—SIGMAR1—urethra—prostate cancer	0.00693	0.0838	CbGeAlD
Naftifine—SQLE—Activation of gene expression by SREBF (SREBP)—RXRA—prostate cancer	0.00686	0.0258	CbGpPWpGaD
Naftifine—Erythema—Flutamide—prostate cancer	0.00685	0.0113	CcSEcCtD
Naftifine—SQLE—Regulation of cholesterol biosynthesis by SREBP (SREBF)—NCOA2—prostate cancer	0.00683	0.0257	CbGpPWpGaD
Naftifine—Swelling—Goserelin—prostate cancer	0.0065	0.0107	CcSEcCtD
Naftifine—Inflammation—Estradiol—prostate cancer	0.00646	0.0106	CcSEcCtD
Naftifine—Swelling—Conjugated Estrogens—prostate cancer	0.00644	0.0106	CcSEcCtD
Naftifine—Leukopenia—Nilutamide—prostate cancer	0.00616	0.0102	CcSEcCtD
Naftifine—Erythema—Degarelix—prostate cancer	0.00614	0.0101	CcSEcCtD
Naftifine—Leukopenia—Flutamide—prostate cancer	0.00613	0.0101	CcSEcCtD
Naftifine—Redness—Docetaxel—prostate cancer	0.00598	0.00986	CcSEcCtD
Naftifine—Dermatitis bullous—Conjugated Estrogens—prostate cancer	0.00594	0.0098	CcSEcCtD
Naftifine—Burning sensation—Docetaxel—prostate cancer	0.00581	0.00958	CcSEcCtD
Naftifine—Erythema—Cabazitaxel—prostate cancer	0.00579	0.00954	CcSEcCtD
Naftifine—SQLE—Regulation of cholesterol biosynthesis by SREBP (SREBF)—NCOA1—prostate cancer	0.00576	0.0217	CbGpPWpGaD
Naftifine—SQLE—Regulation of cholesterol biosynthesis by SREBP (SREBF)—RXRA—prostate cancer	0.00548	0.0206	CbGpPWpGaD
Naftifine—Blister—Capecitabine—prostate cancer	0.00542	0.00894	CcSEcCtD
Naftifine—SIGMAR1—bone marrow—prostate cancer	0.00533	0.0645	CbGeAlD
Naftifine—SQLE—Activation of gene expression by SREBF (SREBP)—PPARA—prostate cancer	0.00524	0.0197	CbGpPWpGaD
Naftifine—Leukopenia—Cabazitaxel—prostate cancer	0.00518	0.00854	CcSEcCtD
Naftifine—Pain—Estrone—prostate cancer	0.00517	0.00852	CcSEcCtD
Naftifine—Swelling—Estradiol—prostate cancer	0.00515	0.0085	CcSEcCtD
Naftifine—Inflammation—Etoposide—prostate cancer	0.005	0.00825	CcSEcCtD
Naftifine—Swelling—Mitoxantrone—prostate cancer	0.0048	0.00792	CcSEcCtD
Naftifine—Pain—Nilutamide—prostate cancer	0.0048	0.00792	CcSEcCtD
Naftifine—SIGMAR1—testis—prostate cancer	0.00456	0.0551	CbGeAlD
Naftifine—Pain—Estradiol valerate/Dienogest—prostate cancer	0.00451	0.00744	CcSEcCtD
Naftifine—Pruritus—Estramustine—prostate cancer	0.00448	0.00738	CcSEcCtD
Naftifine—Pain—Degarelix—prostate cancer	0.00429	0.00707	CcSEcCtD
Naftifine—Pruritus—Estrone—prostate cancer	0.00428	0.00705	CcSEcCtD
Naftifine—SQLE—Regulation of cholesterol biosynthesis by SREBP (SREBF)—PPARA—prostate cancer	0.00418	0.0158	CbGpPWpGaD
Naftifine—SQLE—Activation of gene expression by SREBF (SREBP)—CREBBP—prostate cancer	0.00416	0.0157	CbGpPWpGaD
Naftifine—Inflammation—Docetaxel—prostate cancer	0.00416	0.00686	CcSEcCtD
Naftifine—SQLE—SREBP signalling—SIRT1—prostate cancer	0.00408	0.0154	CbGpPWpGaD
Naftifine—Pain—Cabazitaxel—prostate cancer	0.00404	0.00666	CcSEcCtD
Naftifine—Redness—Epirubicin—prostate cancer	0.00403	0.00665	CcSEcCtD
Naftifine—Inflammation—Capecitabine—prostate cancer	0.00403	0.00664	CcSEcCtD
Naftifine—Dizziness—Estrone—prostate cancer	0.004	0.00659	CcSEcCtD
Naftifine—Swelling—Etoposide—prostate cancer	0.00399	0.00659	CcSEcCtD
Naftifine—Rash—Estramustine—prostate cancer	0.00399	0.00658	CcSEcCtD
Naftifine—Dermatitis—Estramustine—prostate cancer	0.00399	0.00657	CcSEcCtD
Naftifine—Pruritus—Nilutamide—prostate cancer	0.00397	0.00655	CcSEcCtD
Naftifine—Headache—Estramustine—prostate cancer	0.00396	0.00654	CcSEcCtD
Naftifine—Pruritus—Flutamide—prostate cancer	0.00395	0.00652	CcSEcCtD
Naftifine—Burning sensation—Epirubicin—prostate cancer	0.00392	0.00646	CcSEcCtD
Naftifine—Rash—Abiraterone—prostate cancer	0.00387	0.00639	CcSEcCtD
Naftifine—Dermatitis—Abiraterone—prostate cancer	0.00387	0.00638	CcSEcCtD
Naftifine—SQLE—SREBP signalling—LPL—prostate cancer	0.00384	0.0144	CbGpPWpGaD
Naftifine—Rash—Estrone—prostate cancer	0.00381	0.00628	CcSEcCtD
Naftifine—Dermatitis—Estrone—prostate cancer	0.00381	0.00628	CcSEcCtD
Naftifine—Headache—Estrone—prostate cancer	0.00379	0.00624	CcSEcCtD
Naftifine—Blister—Epirubicin—prostate cancer	0.00378	0.00623	CcSEcCtD
Naftifine—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.00373	0.00615	CcSEcCtD
Naftifine—Redness—Doxorubicin—prostate cancer	0.00373	0.00615	CcSEcCtD
Naftifine—Dizziness—Nilutamide—prostate cancer	0.00371	0.00612	CcSEcCtD
Naftifine—Dizziness—Flutamide—prostate cancer	0.0037	0.00609	CcSEcCtD
Naftifine—Burning sensation—Doxorubicin—prostate cancer	0.00362	0.00598	CcSEcCtD
Naftifine—Pruritus—Degarelix—prostate cancer	0.00355	0.00585	CcSEcCtD
Naftifine—Rash—Nilutamide—prostate cancer	0.00354	0.00584	CcSEcCtD
Naftifine—Dermatitis—Nilutamide—prostate cancer	0.00354	0.00583	CcSEcCtD
Naftifine—Rash—Flutamide—prostate cancer	0.00352	0.00581	CcSEcCtD
Naftifine—Dermatitis—Flutamide—prostate cancer	0.00352	0.00581	CcSEcCtD
Naftifine—Headache—Nilutamide—prostate cancer	0.00352	0.0058	CcSEcCtD
Naftifine—Headache—Flutamide—prostate cancer	0.0035	0.00577	CcSEcCtD
Naftifine—Blister—Doxorubicin—prostate cancer	0.00349	0.00576	CcSEcCtD
Naftifine—Tamoxifen—SULT1A1—prostate cancer	0.00349	0.114	CrCbGaD
Naftifine—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.00349	0.00575	CcSEcCtD
Naftifine—Pain—Bicalutamide—prostate cancer	0.00347	0.00571	CcSEcCtD
Naftifine—Erythema—Goserelin—prostate cancer	0.00345	0.0057	CcSEcCtD
Naftifine—Erythema—Conjugated Estrogens—prostate cancer	0.00342	0.00564	CcSEcCtD
Naftifine—Stinging—Epirubicin—prostate cancer	0.00336	0.00554	CcSEcCtD
Naftifine—Rash—Estradiol valerate/Dienogest—prostate cancer	0.00333	0.00548	CcSEcCtD
Naftifine—SQLE—Regulation of cholesterol biosynthesis by SREBP (SREBF)—CREBBP—prostate cancer	0.00332	0.0125	CbGpPWpGaD
Naftifine—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.00332	0.00548	CcSEcCtD
Naftifine—Swelling—Docetaxel—prostate cancer	0.00332	0.00547	CcSEcCtD
Naftifine—Dizziness—Degarelix—prostate cancer	0.00332	0.00547	CcSEcCtD
Naftifine—Headache—Estradiol valerate/Dienogest—prostate cancer	0.0033	0.00545	CcSEcCtD
Naftifine—SIGMAR1—lymph node—prostate cancer	0.0033	0.0399	CbGeAlD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—GRHL1—prostate cancer	0.00322	0.0121	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—CBR1—prostate cancer	0.00322	0.0121	CbGpPWpGaD
Naftifine—Swelling—Capecitabine—prostate cancer	0.00321	0.0053	CcSEcCtD
Naftifine—Rash—Degarelix—prostate cancer	0.00316	0.00521	CcSEcCtD
Naftifine—Dermatitis—Degarelix—prostate cancer	0.00316	0.00521	CcSEcCtD
Naftifine—Headache—Degarelix—prostate cancer	0.00314	0.00518	CcSEcCtD
Naftifine—Dizziness—Cabazitaxel—prostate cancer	0.00312	0.00515	CcSEcCtD
Naftifine—Stinging—Doxorubicin—prostate cancer	0.00311	0.00513	CcSEcCtD
Naftifine—Leukopenia—Goserelin—prostate cancer	0.00309	0.0051	CcSEcCtD
Naftifine—Dermatitis bullous—Docetaxel—prostate cancer	0.00306	0.00505	CcSEcCtD
Naftifine—Agranulocytosis—Mitoxantrone—prostate cancer	0.00305	0.00502	CcSEcCtD
Naftifine—Dermatitis bullous—Capecitabine—prostate cancer	0.00297	0.00489	CcSEcCtD
Naftifine—Headache—Cabazitaxel—prostate cancer	0.00296	0.00488	CcSEcCtD
Naftifine—Pruritus—Bicalutamide—prostate cancer	0.00287	0.00473	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—MBTPS1—prostate cancer	0.00282	0.0106	CbGpPWpGaD
Naftifine—Inflammation—Epirubicin—prostate cancer	0.00281	0.00463	CcSEcCtD
Naftifine—SQLE—SREBP signalling—INS—prostate cancer	0.00275	0.0103	CbGpPWpGaD
Naftifine—Erythema—Estradiol—prostate cancer	0.00274	0.00452	CcSEcCtD
Naftifine—Dizziness—Bicalutamide—prostate cancer	0.00268	0.00442	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—DEGS1—prostate cancer	0.00267	0.0101	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—AMACR—prostate cancer	0.00267	0.0101	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—SRD5A2—prostate cancer	0.00267	0.0101	CbGpPWpGaD
Naftifine—Inflammation—Doxorubicin—prostate cancer	0.0026	0.00428	CcSEcCtD
Naftifine—Rash—Bicalutamide—prostate cancer	0.00255	0.00421	CcSEcCtD
Naftifine—Dermatitis—Bicalutamide—prostate cancer	0.00255	0.00421	CcSEcCtD
Naftifine—Erythema—Mitoxantrone—prostate cancer	0.00255	0.00421	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—HSD17B1—prostate cancer	0.00255	0.00959	CbGpPWpGaD
Naftifine—Headache—Bicalutamide—prostate cancer	0.00254	0.00419	CcSEcCtD
Naftifine—Agranulocytosis—Etoposide—prostate cancer	0.00253	0.00418	CcSEcCtD
Naftifine—Pruritus—Ethinyl Estradiol—prostate cancer	0.00242	0.004	CcSEcCtD
Naftifine—Pain—Goserelin—prostate cancer	0.00241	0.00398	CcSEcCtD
Naftifine—Pain—Conjugated Estrogens—prostate cancer	0.00239	0.00394	CcSEcCtD
Naftifine—Leukopenia—Mitoxantrone—prostate cancer	0.00228	0.00377	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—HPGD—prostate cancer	0.00227	0.00855	CbGpPWpGaD
Naftifine—Dizziness—Ethinyl Estradiol—prostate cancer	0.00226	0.00374	CcSEcCtD
Naftifine—Rash—Ethinyl Estradiol—prostate cancer	0.00216	0.00356	CcSEcCtD
Naftifine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00216	0.00356	CcSEcCtD
Naftifine—Headache—Ethinyl Estradiol—prostate cancer	0.00215	0.00354	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	0.00213	0.00804	CbGpPWpGaD
Naftifine—Terbinafine—CYP19A1—prostate cancer	0.00212	0.0693	CrCbGaD
Naftifine—Agranulocytosis—Docetaxel—prostate cancer	0.00211	0.00347	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	0.00208	0.00782	CbGpPWpGaD
Naftifine—Dermatitis bullous—Epirubicin—prostate cancer	0.00207	0.00341	CcSEcCtD
Naftifine—Agranulocytosis—Capecitabine—prostate cancer	0.00204	0.00336	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	0.00202	0.00762	CbGpPWpGaD
Naftifine—Pruritus—Goserelin—prostate cancer	0.00199	0.00329	CcSEcCtD
Naftifine—Pruritus—Conjugated Estrogens—prostate cancer	0.00198	0.00326	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	0.00193	0.00727	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	0.00193	0.00727	CbGpPWpGaD
Naftifine—Dermatitis bullous—Doxorubicin—prostate cancer	0.00191	0.00315	CcSEcCtD
Naftifine—Pain—Estradiol—prostate cancer	0.00191	0.00315	CcSEcCtD
Naftifine—Leukopenia—Etoposide—prostate cancer	0.0019	0.00313	CcSEcCtD
Naftifine—Bedaquiline—CYP3A4—prostate cancer	0.00189	0.062	CrCbGaD
Naftifine—Dizziness—Goserelin—prostate cancer	0.00186	0.00307	CcSEcCtD
Naftifine—Dizziness—Conjugated Estrogens—prostate cancer	0.00185	0.00304	CcSEcCtD
Naftifine—Pain—Mitoxantrone—prostate cancer	0.00178	0.00294	CcSEcCtD
Naftifine—Rash—Goserelin—prostate cancer	0.00178	0.00293	CcSEcCtD
Naftifine—Dermatitis—Goserelin—prostate cancer	0.00178	0.00293	CcSEcCtD
Naftifine—Headache—Goserelin—prostate cancer	0.00177	0.00291	CcSEcCtD
Naftifine—Erythema—Docetaxel—prostate cancer	0.00176	0.00291	CcSEcCtD
Naftifine—SQLE—Metabolism—HAO1—prostate cancer	0.00176	0.00663	CbGpPWpGaD
Naftifine—Rash—Conjugated Estrogens—prostate cancer	0.00176	0.0029	CcSEcCtD
Naftifine—Dermatitis—Conjugated Estrogens—prostate cancer	0.00176	0.0029	CcSEcCtD
Naftifine—Headache—Conjugated Estrogens—prostate cancer	0.00175	0.00288	CcSEcCtD
Naftifine—Erythema—Capecitabine—prostate cancer	0.00171	0.00282	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	0.00164	0.00618	CbGpPWpGaD
Naftifine—Pruritus—Estradiol—prostate cancer	0.00158	0.00261	CcSEcCtD
Naftifine—Leukopenia—Docetaxel—prostate cancer	0.00158	0.0026	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	0.00157	0.00593	CbGpPWpGaD
Naftifine—Terbinafine—CYP2C19—prostate cancer	0.00156	0.0512	CrCbGaD
Naftifine—Leukopenia—Capecitabine—prostate cancer	0.00153	0.00252	CcSEcCtD
Naftifine—Erythema—Prednisone—prostate cancer	0.00152	0.00251	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	0.00151	0.00571	CbGpPWpGaD
Naftifine—Toremifene—ESR1—prostate cancer	0.00151	0.0496	CrCbGaD
Naftifine—Phenoxybenzamine—SLC22A3—prostate cancer	0.00151	0.0495	CrCbGaD
Naftifine—Pain—Etoposide—prostate cancer	0.00148	0.00244	CcSEcCtD
Naftifine—Dizziness—Estradiol—prostate cancer	0.00148	0.00244	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	0.00146	0.00551	CbGpPWpGaD
Naftifine—SQLE—Metabolism—TST—prostate cancer	0.00144	0.00541	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CSAD—prostate cancer	0.00144	0.00541	CbGpPWpGaD
Naftifine—SQLE—Metabolism—GRHL1—prostate cancer	0.00144	0.00541	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CBR1—prostate cancer	0.00144	0.00541	CbGpPWpGaD
Naftifine—SQLE—Metabolism—ADI1—prostate cancer	0.00144	0.00541	CbGpPWpGaD
Naftifine—SQLE—Metabolism—PSAT1—prostate cancer	0.00144	0.00541	CbGpPWpGaD
Naftifine—Agranulocytosis—Epirubicin—prostate cancer	0.00142	0.00234	CcSEcCtD
Naftifine—Rash—Estradiol—prostate cancer	0.00141	0.00232	CcSEcCtD
Naftifine—Dermatitis—Estradiol—prostate cancer	0.00141	0.00232	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	0.0014	0.00528	CbGpPWpGaD
Naftifine—Headache—Estradiol—prostate cancer	0.0014	0.00231	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	0.00138	0.00518	CbGpPWpGaD
Naftifine—SQLE—SREBP signalling—PIK3CA—prostate cancer	0.00136	0.0051	CbGpPWpGaD
Naftifine—SQLE—Metabolism—UGT2B17—prostate cancer	0.00133	0.00502	CbGpPWpGaD
Naftifine—SQLE—Metabolism—UGT2B15—prostate cancer	0.00133	0.00502	CbGpPWpGaD
Naftifine—SQLE—Metabolism—GRHPR—prostate cancer	0.00133	0.00502	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CKMT2—prostate cancer	0.00133	0.00502	CbGpPWpGaD
Naftifine—Agranulocytosis—Doxorubicin—prostate cancer	0.00131	0.00217	CcSEcCtD
Naftifine—Rash—Mitoxantrone—prostate cancer	0.00131	0.00217	CcSEcCtD
Naftifine—Dermatitis—Mitoxantrone—prostate cancer	0.00131	0.00216	CcSEcCtD
Naftifine—Headache—Mitoxantrone—prostate cancer	0.0013	0.00215	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	0.0013	0.00491	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—MED12—prostate cancer	0.00128	0.00483	CbGpPWpGaD
Naftifine—SQLE—Metabolism—RFK—prostate cancer	0.00125	0.00472	CbGpPWpGaD
Naftifine—SQLE—Metabolism—GSTM3—prostate cancer	0.00125	0.00472	CbGpPWpGaD
Naftifine—SQLE—Metabolism—AOX1—prostate cancer	0.00125	0.00472	CbGpPWpGaD
Naftifine—SQLE—Metabolism—PGAM2—prostate cancer	0.00125	0.00472	CbGpPWpGaD
Naftifine—SQLE—Metabolism—NAGLU—prostate cancer	0.00125	0.00472	CbGpPWpGaD
Naftifine—SQLE—Metabolism—SULT2B1—prostate cancer	0.00125	0.00472	CbGpPWpGaD
Naftifine—SQLE—Metabolism—MBTPS1—prostate cancer	0.00125	0.00472	CbGpPWpGaD
Naftifine—Pain—Docetaxel—prostate cancer	0.00123	0.00203	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	0.00123	0.00462	CbGpPWpGaD
Naftifine—Pruritus—Etoposide—prostate cancer	0.00123	0.00202	CcSEcCtD
Naftifine—Toremifene—CYP1A1—prostate cancer	0.00121	0.0397	CrCbGaD
Naftifine—Pain—Capecitabine—prostate cancer	0.00119	0.00197	CcSEcCtD
Naftifine—Erythema—Epirubicin—prostate cancer	0.00119	0.00196	CcSEcCtD
Naftifine—SQLE—Metabolism—CYP3A43—prostate cancer	0.00119	0.00448	CbGpPWpGaD
Naftifine—SQLE—Metabolism—DEGS1—prostate cancer	0.00119	0.00448	CbGpPWpGaD
Naftifine—SQLE—Metabolism—NAT1—prostate cancer	0.00119	0.00448	CbGpPWpGaD
Naftifine—SQLE—Metabolism—AMACR—prostate cancer	0.00119	0.00448	CbGpPWpGaD
Naftifine—SQLE—Metabolism—SRD5A2—prostate cancer	0.00119	0.00448	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	0.00117	0.00441	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	0.00116	0.00438	CbGpPWpGaD
Naftifine—Dizziness—Etoposide—prostate cancer	0.00115	0.00189	CcSEcCtD
Naftifine—SQLE—Metabolism—HSD17B1—prostate cancer	0.00113	0.00427	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	0.00113	0.00427	CbGpPWpGaD
Naftifine—Diphenhydramine—CYP2C18—prostate cancer	0.00111	0.0364	CrCbGaD
Naftifine—SQLE—SREBP signalling—AKT1—prostate cancer	0.00111	0.00417	CbGpPWpGaD
Naftifine—Erythema—Doxorubicin—prostate cancer	0.0011	0.00182	CcSEcCtD
Naftifine—Rash—Etoposide—prostate cancer	0.00109	0.0018	CcSEcCtD
Naftifine—Dermatitis—Etoposide—prostate cancer	0.00109	0.0018	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	0.00109	0.00411	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	0.00109	0.00409	CbGpPWpGaD
Naftifine—Headache—Etoposide—prostate cancer	0.00108	0.00179	CcSEcCtD
Naftifine—Phenoxybenzamine—SLC22A1—prostate cancer	0.00108	0.0355	CrCbGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	0.00107	0.00404	CbGpPWpGaD
Naftifine—Leukopenia—Epirubicin—prostate cancer	0.00106	0.00176	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	0.00102	0.00385	CbGpPWpGaD
Naftifine—Pruritus—Docetaxel—prostate cancer	0.00102	0.00168	CcSEcCtD
Naftifine—SQLE—Metabolism—HPGD—prostate cancer	0.00101	0.00381	CbGpPWpGaD
Naftifine—SQLE—Metabolism—B4GALT4—prostate cancer	0.00101	0.00381	CbGpPWpGaD
Naftifine—Terbinafine—CYP3A4—prostate cancer	0.000993	0.0326	CrCbGaD
Naftifine—Cinnarizine—CYP2A6—prostate cancer	0.000987	0.0324	CrCbGaD
Naftifine—Pruritus—Capecitabine—prostate cancer	0.000986	0.00163	CcSEcCtD
Naftifine—Leukopenia—Doxorubicin—prostate cancer	0.000985	0.00162	CcSEcCtD
Naftifine—Tamoxifen—ESR2—prostate cancer	0.000981	0.0322	CrCbGaD
Naftifine—Cinacalcet—CYP3A4—prostate cancer	0.000956	0.0313	CrCbGaD
Naftifine—Dizziness—Docetaxel—prostate cancer	0.000952	0.00157	CcSEcCtD
Naftifine—SQLE—Metabolism—TNFRSF21—prostate cancer	0.000951	0.00358	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CYP7B1—prostate cancer	0.000925	0.00348	CbGpPWpGaD
Naftifine—SQLE—Metabolism—MTAP—prostate cancer	0.000925	0.00348	CbGpPWpGaD
Naftifine—Dizziness—Capecitabine—prostate cancer	0.000922	0.00152	CcSEcCtD
Naftifine—Rash—Docetaxel—prostate cancer	0.000908	0.0015	CcSEcCtD
Naftifine—Diphenhydramine—SLC22A1—prostate cancer	0.000907	0.0297	CrCbGaD
Naftifine—Dermatitis—Docetaxel—prostate cancer	0.000907	0.0015	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	0.000904	0.0034	CbGpPWpGaD
Naftifine—Headache—Docetaxel—prostate cancer	0.000902	0.00149	CcSEcCtD
Naftifine—SQLE—Metabolism—SULT1E1—prostate cancer	0.000901	0.00339	CbGpPWpGaD
Naftifine—SQLE—Metabolism—SRD5A1—prostate cancer	0.000901	0.00339	CbGpPWpGaD
Naftifine—Tamoxifen—CYP1B1—prostate cancer	0.000895	0.0293	CrCbGaD
Naftifine—Rash—Capecitabine—prostate cancer	0.000879	0.00145	CcSEcCtD
Naftifine—Pruritus—Prednisone—prostate cancer	0.000878	0.00145	CcSEcCtD
Naftifine—Dermatitis—Capecitabine—prostate cancer	0.000878	0.00145	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	0.000875	0.0033	CbGpPWpGaD
Naftifine—Headache—Capecitabine—prostate cancer	0.000873	0.00144	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	0.000862	0.00325	CbGpPWpGaD
Naftifine—SQLE—Metabolism—ACSL4—prostate cancer	0.00086	0.00324	CbGpPWpGaD
Naftifine—SQLE—Metabolism—HSD17B3—prostate cancer	0.00086	0.00324	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	0.00085	0.0032	CbGpPWpGaD
Naftifine—Pain—Epirubicin—prostate cancer	0.00083	0.00137	CcSEcCtD
Naftifine—SQLE—Metabolism—ARG2—prostate cancer	0.000824	0.0031	CbGpPWpGaD
Naftifine—SQLE—Metabolism—UMPS—prostate cancer	0.000824	0.0031	CbGpPWpGaD
Naftifine—SQLE—Metabolism—PHGDH—prostate cancer	0.000824	0.0031	CbGpPWpGaD
Naftifine—Dizziness—Prednisone—prostate cancer	0.000821	0.00135	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	0.00082	0.00309	CbGpPWpGaD
Naftifine—SQLE—Metabolism—LDHB—prostate cancer	0.000808	0.00304	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CYP3A5—prostate cancer	0.000793	0.00299	CbGpPWpGaD
Naftifine—Rash—Prednisone—prostate cancer	0.000783	0.00129	CcSEcCtD
Naftifine—Dermatitis—Prednisone—prostate cancer	0.000782	0.00129	CcSEcCtD
Naftifine—Headache—Prednisone—prostate cancer	0.000778	0.00128	CcSEcCtD
Naftifine—Toremifene—CYP3A4—prostate cancer	0.000772	0.0253	CrCbGaD
Naftifine—Pain—Doxorubicin—prostate cancer	0.000768	0.00127	CcSEcCtD
Naftifine—SQLE—Metabolism—TCN2—prostate cancer	0.000766	0.00289	CbGpPWpGaD
Naftifine—SQLE—Metabolism—UCP3—prostate cancer	0.000766	0.00289	CbGpPWpGaD
Naftifine—SQLE—Metabolism—GSTA3—prostate cancer	0.000766	0.00289	CbGpPWpGaD
Naftifine—SQLE—Metabolism—PDHA1—prostate cancer	0.000766	0.00289	CbGpPWpGaD
Naftifine—SQLE—Metabolism—SLC22A3—prostate cancer	0.000731	0.00275	CbGpPWpGaD
Naftifine—SQLE—Metabolism—HSD3B1—prostate cancer	0.000731	0.00275	CbGpPWpGaD
Naftifine—Tamoxifen—CYP3A5—prostate cancer	0.000713	0.0234	CrCbGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—LPL—prostate cancer	0.000709	0.00267	CbGpPWpGaD
Naftifine—SQLE—Metabolism—GSTA4—prostate cancer	0.000701	0.00264	CbGpPWpGaD
Naftifine—SQLE—Metabolism—TBXAS1—prostate cancer	0.000701	0.00264	CbGpPWpGaD
Naftifine—Cinnarizine—CYP1A1—prostate cancer	0.000691	0.0227	CrCbGaD
Naftifine—Phenoxybenzamine—ADRB2—prostate cancer	0.00069	0.0226	CrCbGaD
Naftifine—Tamoxifen—CYP2A6—prostate cancer	0.00069	0.0226	CrCbGaD
Naftifine—Pruritus—Epirubicin—prostate cancer	0.000687	0.00113	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	0.000685	0.00258	CbGpPWpGaD
Naftifine—SQLE—Metabolism—GSTA2—prostate cancer	0.000683	0.00257	CbGpPWpGaD
Naftifine—SQLE—Metabolism—SULT1A1—prostate cancer	0.000675	0.00254	CbGpPWpGaD
Naftifine—SQLE—Metabolism—ABCG5—prostate cancer	0.000675	0.00254	CbGpPWpGaD
Naftifine—Cyclobenzaprine—CYP3A4—prostate cancer	0.000668	0.0219	CrCbGaD
Naftifine—SQLE—Metabolism—GSTA1—prostate cancer	0.000659	0.00248	CbGpPWpGaD
Naftifine—Tamoxifen—CYP19A1—prostate cancer	0.000657	0.0215	CrCbGaD
Naftifine—SQLE—Metabolism—NAT2—prostate cancer	0.000652	0.00245	CbGpPWpGaD
Naftifine—SQLE—Metabolism—HSD3B2—prostate cancer	0.000652	0.00245	CbGpPWpGaD
Naftifine—SQLE—Metabolism—GSTO1—prostate cancer	0.000652	0.00245	CbGpPWpGaD
Naftifine—Dizziness—Epirubicin—prostate cancer	0.000642	0.00106	CcSEcCtD
Naftifine—Pruritus—Doxorubicin—prostate cancer	0.000636	0.00105	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	0.000627	0.00236	CbGpPWpGaD
Naftifine—SQLE—Metabolism—PLCB2—prostate cancer	0.000625	0.00235	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CYP2C18—prostate cancer	0.000625	0.00235	CbGpPWpGaD
Naftifine—SQLE—Metabolism—LRP2—prostate cancer	0.000625	0.00235	CbGpPWpGaD
Naftifine—SQLE—Metabolism—P4HB—prostate cancer	0.000613	0.00231	CbGpPWpGaD
Naftifine—Rash—Epirubicin—prostate cancer	0.000612	0.00101	CcSEcCtD
Naftifine—Dermatitis—Epirubicin—prostate cancer	0.000612	0.00101	CcSEcCtD
Naftifine—Headache—Epirubicin—prostate cancer	0.000608	0.001	CcSEcCtD
Naftifine—Tamoxifen—ESR1—prostate cancer	0.000605	0.0198	CrCbGaD
Naftifine—SQLE—Metabolism—SLC22A1—prostate cancer	0.000596	0.00224	CbGpPWpGaD
Naftifine—Dizziness—Doxorubicin—prostate cancer	0.000594	0.00098	CcSEcCtD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	0.000589	0.00222	CbGpPWpGaD
Naftifine—SQLE—Metabolism—SULT2A1—prostate cancer	0.000581	0.00219	CbGpPWpGaD
Naftifine—SQLE—Metabolism—MED12—prostate cancer	0.000571	0.00215	CbGpPWpGaD
Naftifine—SQLE—Metabolism—GNG5—prostate cancer	0.000567	0.00213	CbGpPWpGaD
Naftifine—Rash—Doxorubicin—prostate cancer	0.000566	0.000934	CcSEcCtD
Naftifine—Dermatitis—Doxorubicin—prostate cancer	0.000566	0.000933	CcSEcCtD
Naftifine—Headache—Doxorubicin—prostate cancer	0.000563	0.000928	CcSEcCtD
Naftifine—SQLE—Metabolism—NCOA3—prostate cancer	0.000546	0.00206	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	0.000537	0.00202	CbGpPWpGaD
Naftifine—SQLE—Metabolism—HPGDS—prostate cancer	0.000521	0.00196	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CYP2C19—prostate cancer	0.000518	0.00195	CbGpPWpGaD
Naftifine—SQLE—Metabolism—GSTT1—prostate cancer	0.000505	0.0019	CbGpPWpGaD
Naftifine—SQLE—Metabolism—ACHE—prostate cancer	0.000505	0.0019	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CYP2A6—prostate cancer	0.000499	0.00188	CbGpPWpGaD
Naftifine—Diphenhydramine—CYP2C19—prostate cancer	0.000498	0.0163	CrCbGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	0.000497	0.00187	CbGpPWpGaD
Naftifine—Tamoxifen—CYP2E1—prostate cancer	0.00049	0.0161	CrCbGaD
Naftifine—SQLE—Metabolism—AKR1C3—prostate cancer	0.000486	0.00183	CbGpPWpGaD
Naftifine—Tamoxifen—CYP2C19—prostate cancer	0.000485	0.0159	CrCbGaD
Naftifine—Tamoxifen—CYP1A1—prostate cancer	0.000483	0.0158	CrCbGaD
Naftifine—SQLE—Metabolism—PRKACB—prostate cancer	0.000483	0.00182	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CYP17A1—prostate cancer	0.000478	0.0018	CbGpPWpGaD
Naftifine—Orphenadrine—CYP2E1—prostate cancer	0.000476	0.0156	CrCbGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	0.000472	0.00178	CbGpPWpGaD
Naftifine—SQLE—Metabolism—NCOA2—prostate cancer	0.000456	0.00172	CbGpPWpGaD
Naftifine—SQLE—Metabolism—SLC5A5—prostate cancer	0.000435	0.00164	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CYP2E1—prostate cancer	0.000425	0.0016	CbGpPWpGaD
Naftifine—SQLE—Metabolism—NQO1—prostate cancer	0.00042	0.00158	CbGpPWpGaD
Naftifine—SQLE—Metabolism—TH—prostate cancer	0.000414	0.00156	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	0.000411	0.00155	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CYP3A4—prostate cancer	0.000409	0.00154	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	0.000407	0.00153	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CYP1B1—prostate cancer	0.000403	0.00152	CbGpPWpGaD
Naftifine—Benzphetamine—CYP3A4—prostate cancer	0.000395	0.013	CrCbGaD
Naftifine—SQLE—Metabolism—GGT1—prostate cancer	0.00039	0.00147	CbGpPWpGaD
Naftifine—SQLE—Metabolism—NCOA1—prostate cancer	0.000384	0.00145	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CYP19A1—prostate cancer	0.000378	0.00143	CbGpPWpGaD
Naftifine—Phenoxybenzamine—CYP3A4—prostate cancer	0.000378	0.0124	CrCbGaD
Naftifine—SQLE—Metabolism—RXRA—prostate cancer	0.000365	0.00138	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	0.000355	0.00134	CbGpPWpGaD
Naftifine—SQLE—Metabolism—COMT—prostate cancer	0.000352	0.00133	CbGpPWpGaD
Naftifine—SQLE—Metabolism—GSTP1—prostate cancer	0.00035	0.00132	CbGpPWpGaD
Naftifine—SQLE—Metabolism—ITPR1—prostate cancer	0.000345	0.0013	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—EP300—prostate cancer	0.000339	0.00128	CbGpPWpGaD
Naftifine—SQLE—Metabolism—TYMS—prostate cancer	0.000326	0.00123	CbGpPWpGaD
Naftifine—SQLE—Metabolism—GSTM1—prostate cancer	0.000322	0.00121	CbGpPWpGaD
Naftifine—SQLE—Metabolism—LPL—prostate cancer	0.000316	0.00119	CbGpPWpGaD
Naftifine—Tamoxifen—CYP3A4—prostate cancer	0.000309	0.0101	CrCbGaD
Naftifine—SQLE—Metabolism—CYP1A1—prostate cancer	0.000305	0.00115	CbGpPWpGaD
Naftifine—SQLE—Metabolism—ERCC2—prostate cancer	0.000303	0.00114	CbGpPWpGaD
Naftifine—Orphenadrine—CYP3A4—prostate cancer	0.0003	0.00983	CrCbGaD
Naftifine—SQLE—Metabolism—MTHFR—prostate cancer	0.000284	0.00107	CbGpPWpGaD
Naftifine—SQLE—Metabolism—PPARA—prostate cancer	0.000279	0.00105	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CAV1—prostate cancer	0.000262	0.000988	CbGpPWpGaD
Naftifine—SQLE—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	0.000251	0.000944	CbGpPWpGaD
Naftifine—SQLE—Metabolism—PIK3CG—prostate cancer	0.000239	0.0009	CbGpPWpGaD
Naftifine—SQLE—Metabolism—INS—prostate cancer	0.000226	0.000852	CbGpPWpGaD
Naftifine—SQLE—Metabolism—CREBBP—prostate cancer	0.000222	0.000834	CbGpPWpGaD
Naftifine—SQLE—Metabolism—PIK3CD—prostate cancer	0.00021	0.000791	CbGpPWpGaD
Naftifine—SQLE—Metabolism—NOS3—prostate cancer	0.000198	0.000747	CbGpPWpGaD
Naftifine—SQLE—Metabolism—PIK3CB—prostate cancer	0.000183	0.00069	CbGpPWpGaD
Naftifine—SQLE—Metabolism—PTGS2—prostate cancer	0.000181	0.000683	CbGpPWpGaD
Naftifine—SQLE—Metabolism—PTEN—prostate cancer	0.000158	0.000596	CbGpPWpGaD
Naftifine—SQLE—Metabolism—EP300—prostate cancer	0.000151	0.000568	CbGpPWpGaD
Naftifine—SQLE—Metabolism—PIK3CA—prostate cancer	0.000112	0.00042	CbGpPWpGaD
Naftifine—SQLE—Metabolism—AKT1—prostate cancer	9.12e-05	0.000343	CbGpPWpGaD
